Standard
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. / Gejl, M; Søndergaard, H M; Stecher, Chalotte Willemann; Bibby, Bo Martin; Møller, N; Bøtker, H E; Hansen, S B; Gjedde, Albert; Rungby, Jørgen; Brock, B.
In:
The Journal of clinical endocrinology and metabolism, Vol. 97, No. 7, 07.2012, p. E1165-9.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Gejl, M, Søndergaard, HM, Stecher, CW, Bibby, BM, Møller, N, Bøtker, HE, Hansen, SB
, Gjedde, A, Rungby, J & Brock, B 2012, '
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes',
The Journal of clinical endocrinology and metabolism, vol. 97, no. 7, pp. E1165-9.
https://doi.org/10.1210/jc.2011-3456APA
Gejl, M., Søndergaard, H. M., Stecher, C. W., Bibby, B. M., Møller, N., Bøtker, H. E., Hansen, S. B.
, Gjedde, A., Rungby, J., & Brock, B. (2012).
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism,
97(7), E1165-9.
https://doi.org/10.1210/jc.2011-3456Vancouver
Gejl M, Søndergaard HM, Stecher CW, Bibby BM, Møller N, Bøtker HE et al.
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism. 2012 Jul;97(7):E1165-9.
https://doi.org/10.1210/jc.2011-3456Author
Gejl, M ; Søndergaard, H M ; Stecher, Chalotte Willemann ; Bibby, Bo Martin ; Møller, N ; Bøtker, H E ; Hansen, S B ; Gjedde, Albert ; Rungby, Jørgen ; Brock, B. / Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. In: The Journal of clinical endocrinology and metabolism. 2012 ; Vol. 97, No. 7. pp. E1165-9.
Bibtex
@article{a7ad41666b55486fa829d82c2358d1d0,
title = "Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes",
abstract = "Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonists provide beneficial cardiovascular effects by protecting against ischemia and reperfusion injury. Type 2 diabetes mellitus patients have reduced glycolysis in the heart.",
keywords = "Biological Transport, Coronary Circulation, Cross-Over Studies, Diabetes Mellitus, Type 2, Double-Blind Method, Glucose, Heart, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Middle Aged, Myocardium, Peptides, Placebos, Positron-Emission Tomography, Regional Blood Flow, Up-Regulation, Venoms",
author = "M Gejl and S{\o}ndergaard, {H M} and Stecher, {Chalotte Willemann} and Bibby, {Bo Martin} and N M{\o}ller and B{\o}tker, {H E} and Hansen, {S B} and Albert Gjedde and J{\o}rgen Rungby and B Brock",
year = "2012",
month = jul,
doi = "10.1210/jc.2011-3456",
language = "English",
volume = "97",
pages = "E1165--9",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "7",
}
RIS
TY - JOUR
T1 - Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes
AU - Gejl, M
AU - Søndergaard, H M
AU - Stecher, Chalotte Willemann
AU - Bibby, Bo Martin
AU - Møller, N
AU - Bøtker, H E
AU - Hansen, S B
AU - Gjedde, Albert
AU - Rungby, Jørgen
AU - Brock, B
PY - 2012/7
Y1 - 2012/7
N2 - Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonists provide beneficial cardiovascular effects by protecting against ischemia and reperfusion injury. Type 2 diabetes mellitus patients have reduced glycolysis in the heart.
AB - Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonists provide beneficial cardiovascular effects by protecting against ischemia and reperfusion injury. Type 2 diabetes mellitus patients have reduced glycolysis in the heart.
KW - Biological Transport
KW - Coronary Circulation
KW - Cross-Over Studies
KW - Diabetes Mellitus, Type 2
KW - Double-Blind Method
KW - Glucose
KW - Heart
KW - Humans
KW - Hypoglycemic Agents
KW - Insulin Resistance
KW - Male
KW - Middle Aged
KW - Myocardium
KW - Peptides
KW - Placebos
KW - Positron-Emission Tomography
KW - Regional Blood Flow
KW - Up-Regulation
KW - Venoms
U2 - 10.1210/jc.2011-3456
DO - 10.1210/jc.2011-3456
M3 - Journal article
C2 - 22544917
VL - 97
SP - E1165-9
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 7
ER -
